Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis.

Peluso R, Caso F, Tasso M, Sabbatino V, Lupoli R, Dario Di Minno MN, Ursini F, Costa L, Scarpa R.

Open Access Rheumatol. 2019 Jun 28;11:143-156. doi: 10.2147/OARRR.S206931. eCollection 2019. Review.

2.

Predominant ultrasonographic extracapsular changes in symptomatic psoriatic dactylitis: results from a multicenter cross-sectional study comparing symptomatic and asymptomatic hand dactylitis.

Girolimetto N, Macchioni P, Tinazzi I, Costa L, Peluso R, Tasso M, Bascherini V, Addimanda O, Marchetta A, Possemato N, Salvarani C, McGonagle D, Scarpa R, Caso F.

Clin Rheumatol. 2019 Jul 13. doi: 10.1007/s10067-019-04683-2. [Epub ahead of print]

PMID:
31302859
3.

Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management.

Caso F, Tasso M, Chimenti MS, Navarini L, Perricone C, Girolimetto N, Peluso R, Del Puente A, Afeltra A, Perricone R, Punzi L, Scarpa R, Costa L.

Drugs Aging. 2019 Jun 27. doi: 10.1007/s40266-019-00688-3. [Epub ahead of print] Review.

PMID:
31250280
4.

Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis".

Caso F, Postiglione L, Covelli B, Ricciardone M, Di Spigna G, Formisano P, D'Esposito V, Girolimetto N, Tasso M, Peluso R, Navarini L, Ciccozzi M, Margiotta DPE, Oliviero F, Afeltra A, Punzi L, Del Puente A, Scarpa R, Costa L.

Clin Rheumatol. 2019 May 30. doi: 10.1007/s10067-019-04619-w. [Epub ahead of print]

PMID:
31147798
5.

Ultrasonographic evidence of predominance of acute extracapsular and chronic intrasynovial patterns in 100 psoriatic hand dactylitis.

Girolimetto N, Macchioni P, Tinazzi I, Costa L, McGonagle D, Peluso R, Del Puente A, Addimanda O, Marchetta A, Possemato N, Tasso M, Salvarani C, Scarpa R, Caso F.

J Rheumatol. 2019 May 15. pii: jrheum.190046. doi: 10.3899/jrheum.190046. [Epub ahead of print]

PMID:
31092722
6.

First muography of Stromboli volcano.

Tioukov V, Alexandrov A, Bozza C, Consiglio L, D'Ambrosio N, De Lellis G, De Sio C, Giudicepietro F, Macedonio G, Miyamoto S, Nishiyama R, Orazi M, Peluso R, Sheshukov A, Sirignano C, Stellacci SM, Strolin P, Tanaka HKM.

Sci Rep. 2019 Apr 30;9(1):6695. doi: 10.1038/s41598-019-43131-8.

7.

Symptomatic psoriatic dactylitis is associated with ultrasound determined extra-synovial inflammatory features and shorter disease duration.

Girolimetto N, Costa L, Mancarella L, Addimanda O, Bottiglieri P, Santelli F, Meliconi R, Peluso R, Del Puente A, Macchioni P, Salvarani C, McGonagle D, Scarpa R, Caso F.

Clin Rheumatol. 2019 Mar;38(3):903-911. doi: 10.1007/s10067-018-4400-z. Epub 2018 Dec 19.

PMID:
30569440
8.

Volcanoes in Italy and the role of muon radiography.

D'Alessandro R, Ambrosino F, Baccani G, Bonechi L, Bongi M, Caputo A, Ciaranfi R, Cimmino L, Ciulli V, D'Errico M, Giudicepietro F, Gonzi S, Macedonio G, Masone V, Melon B, Mori N, Noli P, Orazi M, Passeggio P, Peluso R, Saracino G, Scognamiglio L, Strolin P, Vertechi E, Viliani L.

Philos Trans A Math Phys Eng Sci. 2018 Dec 10;377(2137). pii: 20180050. doi: 10.1098/rsta.2018.0050.

PMID:
30530551
9.

Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study.

Di Minno MND, Emmi G, Ambrosino P, Scalera A, Tufano A, Cafaro G, Peluso R, Bettiol A, Di Scala G, Silvestri E, Prisco D.

Int J Cardiol. 2019 Jan 1;274:1-6. doi: 10.1016/j.ijcard.2018.06.010. Epub 2018 Jun 5.

PMID:
30454720
10.

Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies.

Di Minno MND, Emmi G, Ambrosino P, Scalera A, Tufano A, Cafaro G, Peluso R, Bettiol A, Di Scala G, Silvestri E, Prisco D.

Data Brief. 2018 Jun 27;19:1799-1803. doi: 10.1016/j.dib.2018.06.083. eCollection 2018 Aug.

11.

Insulin-Sensiting Effects of Tumor Necrosis Factor Alpha Inhibitors in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.

Leporini C, Russo E, D Angelo S, Arturi F, Tripepi G, Peluso R, Grembiale RD, Olivieri I, De Sarro G, Ursini F.

Rev Recent Clin Trials. 2018;13(3):184-191. doi: 10.2174/1574887113666180314100340.

PMID:
29542420
12.

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients.

Peluso R, Caso F, Tasso M, Ambrosino P, Dario Di Minno MN, Lupoli R, Criscuolo L, Caso P, Ursini F, Puente AD, Scarpa R, Costa On Behalf Of CaRRDs Study Group L.

Rev Recent Clin Trials. 2018;13(3):199-209. doi: 10.2174/1574887113666180314105511.

PMID:
29542417
13.

Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study.

Caso F, Del Puente A, Oliviero F, Peluso R, Girolimetto N, Bottiglieri P, Foglia F, Benigno C, Tasso M, Punzi L, Scarpa R, Costa L.

Clin Rheumatol. 2018 Mar;37(3):579-586. doi: 10.1007/s10067-017-3975-0. Epub 2018 Jan 8. Review.

PMID:
29313273
14.

Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence.

Costa L, Perricone C, Chimenti MS, Del Puente A, Caso P, Peluso R, Bottiglieri P, Scarpa R, Caso F.

Drugs R D. 2017 Dec;17(4):509-522. doi: 10.1007/s40268-017-0215-7. Review.

15.

Improvement of Bone Physiology and Life Quality Due to Association of Risedronate and Anastrozole.

Monda V, Lupoli GA, Messina G, Peluso R, Panico A, Villano I, Salerno M, Sessa F, Marciello F, Moscatelli F, Valenzano A, Molino L, Lupoli R, Fonderico F, Tortora A, Pisano A, Ruberto M, Gabriella M, Cavaliere G, Trinchese G, Mollica MP, Cipolloni L, Cibelli G, Monda M, Lupoli G, Messina A.

Front Pharmacol. 2017 Sep 12;8:632. doi: 10.3389/fphar.2017.00632. eCollection 2017.

16.

Small molecule therapy for managing moderate to severe psoriatic arthritis.

Costa L, Del Puente A, Peluso R, Tasso M, Caso P, Chimenti MS, Sabbatino V, Girolimetto N, Benigno C, Bertolini N, Del Puente A, Perricone R, Scarpa R, Caso F.

Expert Opin Pharmacother. 2017 Oct;18(15):1557-1567. doi: 10.1080/14656566.2017.1378343. Epub 2017 Sep 18. Review.

PMID:
28891341
17.

Psoriatic Disease 10 Years Later.

Scarpa R, Caso F, Costa L, Peluso R, Del Puente A, Olivieri I.

J Rheumatol. 2017 Sep;44(9):1298-1301. doi: 10.3899/jrheum.161402. No abstract available.

PMID:
28864664
18.

Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate.

Costa L, Lubrano E, Ramonda R, Chimenti MS, Vezzù M, Perrotta FM, Del Puente A, Peluso R, Bottiglieri P, Lorenzin M, Sunzini F, Darda MA, Fiocco U, Perricone R, Punzi L, Scarpa R, Caso F.

Clin Rheumatol. 2017 Aug;36(8):1797-1802. doi: 10.1007/s10067-017-3697-3. Epub 2017 Jun 7.

PMID:
28589323
19.

Corrigendum to "Inflammation and frailty in the elderly: A systematic review and meta-analysis" [Ageing Res Rev. 31 (2016) 1-8].

Soysal P, Stubbs B, Lucato P, Luchini C, Solmi M, Peluso R, Sergi G, Isik AT, Manzato E, Maggi S, Maggio M, Prina AM, Cosco TD, Wu YT, Veronese N.

Ageing Res Rev. 2017 May;35:364-365. doi: 10.1016/j.arr.2016.12.007. Epub 2017 Jan 13. No abstract available.

PMID:
28089523
20.

Targeting Taxanes to Castration-Resistant Prostate Cancer Cells by Nanobubbles and Extracorporeal Shock Waves.

Marano F, Rinella L, Argenziano M, Cavalli R, Sassi F, D'Amelio P, Battaglia A, Gontero P, Bosco O, Peluso R, Fortunati N, Frairia R, Catalano MG.

PLoS One. 2016 Dec 21;11(12):e0168553. doi: 10.1371/journal.pone.0168553. eCollection 2016.

21.

Impact of body weight on the achievement of minimal disease activity in patients with rheumatic diseases: a systematic review and meta-analysis.

Lupoli R, Pizzicato P, Scalera A, Ambrosino P, Amato M, Peluso R, Di Minno MN.

Arthritis Res Ther. 2016 Dec 13;18(1):297. Review.

22.

Clinical effects of mud-bath therapy and oral glucosamine sulfate after 6 months of discontinuation in patients with knee osteoarthritis: results from a randomised, controlled, crossover study.

Caso F, Costa L, Del Puente A, Sorbo D, Balestrieri U, Peluso R, Scarpa R.

Clin Exp Rheumatol. 2017 Jan-Feb;35(1):169. Epub 2016 Sep 7. No abstract available.

PMID:
27749217
23.
24.

Inflammation and frailty in the elderly: A systematic review and meta-analysis.

Soysal P, Stubbs B, Lucato P, Luchini C, Solmi M, Peluso R, Sergi G, Isik AT, Manzato E, Maggi S, Maggio M, Prina AM, Cosco TD, Wu YT, Veronese N.

Ageing Res Rev. 2016 Nov;31:1-8. doi: 10.1016/j.arr.2016.08.006. Epub 2016 Aug 31. Review. Erratum in: Ageing Res Rev. 2017 May;35:364-365.

25.

Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis.

Gentile M, Peluso R, Di Minno MND, Costa L, Caso F, de Simone B, Iannuzzo G, Scarpa R, Rubba P.

Clin Rheumatol. 2016 Aug;35(8):2023-2029. doi: 10.1007/s10067-016-3344-4. Epub 2016 Jul 13.

PMID:
27411815
26.

Dactylitis in enteropathic spondyloarthritis.

Peluso R, Costa L, Caso F, Del Puente A, Di Minno MN, Manguso F, Castiglione F, Scarpa R.

Clin Exp Rheumatol. 2016 Sep-Oct;34(5):842-847. Epub 2016 Apr 15.

PMID:
27087311
27.

Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: a randomized, controlled, crossover study.

Peluso R, Caso F, Costa L, Sorbo D, Carraturo N, Di Minno MN, Carraturo F, Oriente A, Balestrieri U, Minicucci A, Del Puente A, Scarpa R.

Clin Exp Rheumatol. 2016 Jul-Aug;34(4):618-24. Epub 2016 Apr 6.

PMID:
27050908
28.

Use of flow cytometry for characterization of human cytomegalovirus vaccine particles.

Vlasak J, Hoang VM, Christanti S, Peluso R, Li F, Culp TD.

Vaccine. 2016 Apr 29;34(20):2321-8. doi: 10.1016/j.vaccine.2016.03.067. Epub 2016 Mar 25.

PMID:
27020711
29.

Influenza vaccine with adjuvant on disease activity in psoriatic arthritis patients under anti-TNF-α therapy.

Caso F, Ramonda R, Del Puente A, Darda MA, Cantarini L, Peluso R, Esposito C, Ortolan A, Fiocco U, Punzi L, Scarpa R, Costa L.

Clin Exp Rheumatol. 2016 May-Jun;34(3):507-12. Epub 2016 Mar 11.

PMID:
26967009
30.

Emerging drugs for psoriatic arthritis.

Caso F, Del Puente A, Peluso R, Caso P, Girolimetto N, Del Puente A, Scarpa R, Costa L.

Expert Opin Emerg Drugs. 2016;21(1):69-79. doi: 10.1517/14728214.2016.1146679. Epub 2016 Feb 15. Review.

PMID:
26807876
31.

Cardiovascular effects of Etanercept in patients with psoriatic arthritis: evidence from the cardiovascular risk in rheumatic diseases database.

Di Minno MN, Iervolino S, Zincarelli C, Lupoli R, Ambrosino P, Pizzicato P, Di Minno A, Pappone N, Peluso R.

Expert Opin Drug Saf. 2015;14(12):1905-13. doi: 10.1517/14740338.2015.1111870. Epub 2015 Nov 30. Review.

PMID:
26618553
32.

Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies.

Caso F, Costa L, Del Puente A, Di Minno MN, Lupoli G, Scarpa R, Peluso R.

Ther Adv Chronic Dis. 2015 Nov;6(6):328-38. doi: 10.1177/2040622315608647. Review.

33.

Progress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis.

Caso F, Lubrano E, Del Puente A, Caso P, Peluso R, Foglia F, Benigno C, Girolimetto N, Bottiglieri P, Scarpa R, Costa L.

Expert Rev Clin Immunol. 2016;12(3):315-31. doi: 10.1586/1744666X.2016.1117941. Epub 2015 Dec 9. Review.

PMID:
26558483
34.

Clinical assessment of endothelial function in patients with rheumatoid arthritis: A meta-analysis of literature studies.

Di Minno MN, Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, Tremoli E.

Eur J Intern Med. 2015 Dec;26(10):835-42. doi: 10.1016/j.ejim.2015.10.016. Epub 2015 Nov 4.

PMID:
26547241
35.

Psoriatic Disease: Clinical Staging.

Scarpa R, Caso F, Costa L, Peluso R, Spanò A, Lubrano E, Del Puente A, Moll JM.

J Rheumatol Suppl. 2015 Nov;93:24-6. doi: 10.3899/jrheum.150629.

PMID:
26523050
36.

The impact of concomitant diffuse idiopathic skeletal hyperostosis on the achievement of minimal disease activity in subjects with psoriatic arthritis.

Pappone N, Di Minno MN, Iervolino S, Lupoli R, Mader R, Zincarelli C, Peluso R.

Rheumatol Int. 2015 Dec;35(12):2041-6. doi: 10.1007/s00296-015-3303-4. Epub 2015 Jun 6.

PMID:
26048625
37.

Cardiovascular risk markers in patients with psoriatic arthritis: A meta-analysis of literature studies.

Di Minno MN, Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, Tremoli E.

Ann Med. 2015 Jun;47(4):346-53. doi: 10.3109/07853890.2015.1031822. Epub 2015 May 8. Review.

PMID:
25953378
38.

Ankylosing spondylitis and posture control: the role of visual input.

De Nunzio AM, Iervolino S, Zincarelli C, Di Gioia L, Rengo G, Multari V, Peluso R, Di Minno MN, Pappone N.

Biomed Res Int. 2015;2015:948674. doi: 10.1155/2015/948674. Epub 2015 Mar 3.

39.

Management of arthropathy in inflammatory bowel diseases.

Peluso R, Manguso F, Vitiello M, Iervolino S, Di Minno MN.

Ther Adv Chronic Dis. 2015 Mar;6(2):65-77. doi: 10.1177/2040622314563929. Review.

40.

Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies.

Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, Di Minno MN.

Thromb Haemost. 2015 May;113(5):916-30. doi: 10.1160/TH14-11-0921. Epub 2015 Feb 26. Review.

PMID:
25716931
41.

Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection.

Caso F, Cantarini L, Morisco F, Del Puente A, Ramonda R, Fiocco U, Lubrano E, Peluso R, Caso P, Galeazzi M, Punzi L, Scarpa R, Costa L.

Expert Opin Biol Ther. 2015 May;15(5):641-50. doi: 10.1517/14712598.2015.1011616. Epub 2015 Feb 4. Review.

PMID:
25652590
42.

Markers of cardiovascular risk in patients with antiphospholipid syndrome: a meta-analysis of literature studies.

Ambrosino P, Lupoli R, Di Minno A, Iervolino S, Peluso R, Di Minno MN.

Ann Med. 2014 Dec;46(8):693-702. doi: 10.3109/07853890.2014.959559. Epub 2014 Oct 13. Review.

PMID:
25307359
43.

Biological therapies for spondyloarthritis.

Bruner V, Atteno M, Spanò A, Scarpa R, Peluso R.

Ther Adv Musculoskelet Dis. 2014 Jun;6(3):92-101. doi: 10.1177/1759720X14535512. Review.

44.

Extra-articular manifestations in psoriatic arthritis patients.

Peluso R, Iervolino S, Vitiello M, Bruner V, Lupoli G, Di Minno MN.

Clin Rheumatol. 2015 Apr;34(4):745-53. doi: 10.1007/s10067-014-2652-9. Epub 2014 May 8.

PMID:
24803233
45.

Hemostatic and fibrinolytic changes are related to inflammatory conditions in patients with psoriatic arthritis--effect of different treatments.

Di Minno MN, Iervolino S, Peluso R, Di Minno A, Ambrosino P, Scarpa R; CaRRDs Study Group.

J Rheumatol. 2014 Apr;41(4):714-22. doi: 10.3899/jrheum.130850. Epub 2014 Feb 15.

PMID:
24532831
46.

Lipid profile changes in patients with rheumatic diseases receiving a treatment with TNF-α blockers: a meta-analysis of prospective studies.

Di Minno MN, Ambrosino P, Peluso R, Di Minno A, Lupoli R, Dentali F; CaRRDs Study Group.

Ann Med. 2014 Mar;46(2):73-83. doi: 10.3109/07853890.2013.874661. Epub 2014 Jan 27. Review.

PMID:
24460516
47.

Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers.

Di Minno MN, Peluso R, Iervolino S, Russolillo A, Lupoli R, Scarpa R; CaRRDs Study Group.

Ann Rheum Dis. 2014 Jun;73(6):1157-62. doi: 10.1136/annrheumdis-2012-202812. Epub 2013 Jun 14.

48.

Enteropathic spondyloarthritis: from diagnosis to treatment.

Peluso R, Di Minno MN, Iervolino S, Manguso F, Tramontano G, Ambrosino P, Esposito C, Scalera A, Castiglione F, Scarpa R.

Clin Dev Immunol. 2013;2013:631408. doi: 10.1155/2013/631408. Epub 2013 Apr 15. Review.

49.

Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies.

Peluso R, Cafaro G, Di Minno A, Iervolino S, Ambrosino P, Lupoli G, Di Minno MN.

Clin Rheumatol. 2013 Jun;32(6):743-53. doi: 10.1007/s10067-013-2252-0. Epub 2013 Apr 16. Review.

PMID:
23588881
50.

Effectiveness of a rehabilitative programme in improving fatigue and function in rheumatoid arthritis patients treated with biologics: a pilot study.

Di Gioia L, Zincarelli C, Di Minno MN, Rengo G, Peluso R, Spanò A, Iervolino S, Pappone N.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2):285-8. Epub 2013 Feb 13.

PMID:
23406843

Supplemental Content

Loading ...
Support Center